|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 63.60 CNY | +1.92% |
|
+0.90% | +44.22% |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 33.73x | 3.23x | 0.43x | 8.53x | 25.57x | 29.62x | 0.29% | 5.25B | ||
| 17.52x | 2.32x | 2.31x | 4.76x | 12.47x | 14.39x | 0.51% | 74.16B | ||
| 23.35x | 2.84x | -1.59x | 4.25x | 12.35x | 14.25x | 2.52% | 59.32B | ||
| 42.17x | 4.22x | 29.82x | 6.35x | 20.62x | 29.71x | 0.59% | 53.15B | ||
| 49.74x | 6.7x | 1.12x | 13.19x | 28.59x | 35.84x | -.--% | 52.8B | ||
| 17x | 1.45x | -4.01x | 2.9x | 8.88x | 10.15x | -.--% | 26.7B | ||
| 86.46x | 8.45x | -0.05x | 10.44x | 93.83x | 107.62x | -.--% | 20.6B | ||
| 16.23x | 3.42x | 0x | 3.16x | 10.03x | 9.63x | -.--% | 19.72B | ||
| 300.52x | 66.4x | 6.2x | 107.13x | 162.73x | 165.96x | - | 18.85B | ||
| -21.73x | - | -1.12x | 31.51x | -31.9x | -31.01x | -.--% | 14.41B | ||
| -617.78x | 2.88x | 5.89x | 4.48x | 11.65x | 25.19x | -.--% | 12.57B | ||
| -15.97x | - | -0.29x | 518.97x | -15.74x | -15.9x | -.--% | 10.78B | ||
| 19.13x | 1.68x | 0.7x | 2.85x | 13.2x | 13.93x | -.--% | 10.34B | ||
| -3.11x | 1.18x | 0.26x | 2.33x | -1.37x | -1.3x | -.--% | 9.96B | ||
| 6.92x | 2.88x | 0.02x | 3.1x | 4.66x | 4.71x | 2.63% | 9.14B | ||
| -257.3x | - | 0.79x | - | - | - | -.--% | 8.32B | ||
| 17.29x | 1.15x | 0.1x | 2.06x | 8.49x | 11.53x | 1.33% | 7.58B | ||
| -39.05x | 164.31x | 1.06x | 11.69x | -48.02x | -42.44x | -.--% | 7.46B | ||
| -26.41x | 1.65x | 0.14x | 4.07x | -27.18x | -27.7x | -.--% | 6.76B | ||
| Average | -18.49x | 17.17x | 2.20x | 41.21x | 16.05x | 19.68x | 0.44% | 22.52B | |
| Weighted average by Cap. | 12.74x | 9.65x | 4.24x | 24.73x | 21.54x | 25.75x | 0.62% |
- Stock Market
- Equities
- 603087 Stock
- Sector Gan & Lee Pharmaceuticals.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















